BackInterpace Biosciences Overview

Interpace Biosciences Total Revenue

Revenue analysis for IDXG.

Quarterly Revenue

$9.03M
↓ 21.56% YoY

As of Mar 2026

Annual Revenue (TTM)

$36.24M
↓ 24.75% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin